HomeCOLL • NASDAQ
add
Collegium Pharmaceutical Inc
Previous close
$29.80
Day range
$28.76 - $30.01
Year range
$27.28 - $42.29
Market cap
932.35M USD
Avg Volume
358.44K
P/E ratio
15.57
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 181.95M | 21.51% |
Operating expense | 114.12M | 69.18% |
Net income | 12.54M | -60.75% |
Net profit margin | 6.89 | -67.70% |
Earnings per share | 1.77 | 12.03% |
EBITDA | 100.12M | 3.06% |
Effective tax rate | 27.41% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 162.76M | -47.59% |
Total assets | 1.66B | 45.51% |
Total liabilities | 1.43B | 51.36% |
Total equity | 228.84M | — |
Shares outstanding | 31.49M | — |
Price to book | 4.09 | — |
Return on assets | 6.61% | — |
Return on capital | 8.95% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 12.54M | -60.75% |
Cash from operations | 84.64M | 15.42% |
Cash from investing | -11.76M | 53.13% |
Cash from financing | -41.28M | 39.14% |
Net change in cash | 31.60M | 261.37% |
Free cash flow | 132.50M | 90.61% |
About
Founded
2002
Website
Employees
357
